First IL-17 Inhibitor Approved in Europe for HS Patients First IL-17 Inhibitor Approved in Europe for HS Patients

The European Commission has approved the first interleukin-17A inhibitor for treating hidradenitis suppurativa.Medscape Medical News

Source: Medscape Medical News Headlines - June 1, 2023 Category: Consumer Health News Tags: Dermatology News Alert Source Type: news